🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07335991
Recruiting Not applicable

Effect of Vitamin A Supplementation on Idiopathic Scoliosis

NCT07335991 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Phase
Not applicable
Started
2025-05-13
Last updated
2026-05-15

Condition(s) studied

Vitamin A DeficiencyIdiopathic Scoliosis

Investigational drug(s) / intervention(s)

Vitamin ANutritional Education

Vitamin A: Vitamin A supplements plus Nutritional Education

Nutritional Education: Nutritional Education Only

Study summary

This study aims to investigate whether vitamin A supplementation can influence spinal curve magnitude in idiopathic scoliosis children and potentially prevent its de novo development.

Eligibility

Sex
ALL
Min age
6 Years
Max age
15 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age between 6 and 15 years. 2. Biochemically confirmed vitamin A deficiency (serum retinol \< 0.20 mg/L) or insufficiency (serum retinol 0.20-0.29 mg/L). 3. Has undergone radiographic evaluation (standing full-spine X-ray) for idiopathic scoliosis at the initial clinic visit. 4. Skeletally immature (Risser sign 0-3) with a major Cobb angle \< 40 degrees at baseline. 5. Written informed consent/assent provided by the participant and legal guardian. Exclusion Criteria: 1. Unwillingness or inability to comply with all study procedures and follow-up visits. 2. Plans to relocate outside the study area within the next 24 months. 3. Previous high-dose vitamin A supplementation therapy within the past 12 months. 4. Clinical signs of severe vitamin A deficiency syndrome (e.g., xerophthalmia, Bitot's spots). 5. Serum vitamin A level \> 0.70 mg/L (to avoid risk of hypervitaminosis A). 6. Severe chronic health conditions that could confound study outcomes, including but not limited to: * Known syndromic, neuromuscular, or congenital musculoskeletal causes of scoliosis. * History of spine surgery or significant spinal trauma. * Spinal tumor. * Leg length discrepancy \> 20 mm. * Other severe chronic diseases (e.g., poorly controlled diabetes, chronic liver or renal disease, malabsorption syndromes). * Severe obesity (body mass index z-score ≥ 3).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Second Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang Recruiting

More Second Affiliated Hospital of Wenzhou Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07335991 on ClinicalTrials.gov ↗ ← All trials in China